Quality Use of Pathology Program

$8 M program for projects that promote and or develop the quality use of pathology.

Background

The Australian Government aims to ensure access to high quality, safe, clinically relevant and cost effective pathology services.

The Quality Use of Pathology Program (QUPP) was established in 1999 under pathology Memorandum of Understanding (MOU) between pathology stakeholders and the Australian Government (represented by the Department of Health and Ageing). There has been a continued commitment to the QUPP in the recent 2011-12, Pathology Funding Agreement. Program funding of up to $2 million per annum is allocated towards supporting innovative approaches to improving the quality of pathology services.

Objectives

The three key objectives of the Quality Use of Pathology Program are:

1. Quality Consumer Services: To develop and improve consumer-focused, accessible and coordinated services that promote informed choice and meet consumer need;

2. Quality Referrals (Requesting/Ordering): To support referral practices that are informed and facilitated by best practice professional relationships and protocols between referrers and providers that are informed by evidence; that maximise health benefits; and that inform and engage consumers; and

3. Quality Pathology Practice: To support professional practice standards that meet consumer and referrer needs and provide evidence-based, best practice, quality-assured services that are safe, cost effective and efficient.

Eligible Projects

For the 2012-13 Funding Round priority will be given to Quality Use of Pathology Program proposals that:

are aimed at reducing risks in pathology requesting/testing/reporting processes
improve pathology service provision and/or access to pathology in regional and rural areas of Australia
will lead to enhanced decision support mechanisms
are aimed at streamlining or coordinating the education of medical students and resident medical officers with respect to the cost effective use of diagnostic pathology services
will improve linkages between patient health information databases that incorporate pathology test results, particularly with a view to examining the impact of pathology testing on clinical outcomes.

Previous Quality Use of Pathology Program proposals for funding which addressed the three key objectives were categorised in the following themes:

risk minimisation strategies, including incident monitoring
quality issues related to emerging technologies
promoting evidence-based practice in pathology requesting and reporting (with a possible focus on new/junior requester groups)
pathology requesting and reporting and consumer focus
e-Health capability (particularly those aspects affecting quality and safety)
workforce capacity and competence
consumer information strategies
access initiatives/awareness-raising of the special needs of high priority target groups
communication and stakeholder engagement to promulgate QUPP investment outcomes

Funding

Quality Use of Pathology Program funding of up to $2 million per annum is allocated towards supporting innovative approaches to improving the quality of pathology services. Both short-term and long-term projects may be considered. However, the funding agreement period(s) will depend on the applications for funding received by the Department.

Timing

Applications for the Quality Use of Pathology Program close 2.00pm Eastern Daylight Saving Time, Thursday 28 March 2013.

Expert Assistance

Writing a good quality grant application is a critical element in the application process. An application needs to be well thought through, written concisely, have clear objectives and purpose, and show clear links to the objectives of the grant guidelines.

The grant application must answer all questions, provide all required information and respond to the merit criteria. It should also reflect your organisation’s business strategy.

Writing a good application takes time and effort, and requires particular writing skills.

Bulletpoint are expert grant consultants and can assist with all aspects of grant preparation.

Call us on (03) 9005 6789 or email to discuss further.

More Information

What is the #1 grant for start-ups?

12,000+ companies access the R&D tax incentive per year that yields a CASH REBATE of up to 43.5%.
This might be perfect your start up.
Do you want to know more?

Bulletpoint is a Melbourne-based consultancy specialising in guiding businesses through the complex process of the R&D tax incentive. With a decade of experience under our belt, we’re proud to be led by Australia’s highest-rated R&D tax consultant. We’ve successfully lodged over 500 R&D claims, demonstrating a proven track record.

Our approach is straightforward and personable, focusing on cutting through the jargon to help businesses truly understand the definition of R&D in government terms. We’re passionate about what we do, and our clients appreciate this, often commenting on the difference our expertise has made to their businesses. They’ve praised us for uncovering grants they wouldn’t have otherwise known about and for making the whole process less stressful for them.

We’re proud to have an average rating of 4.8 stars from over 250 Google reviews. Despite our success, we continue to strive for improvement, learning from every piece of feedback we receive.

At Bulletpoint, we excel in helping businesses navigate the complexities of the R&D tax incentive process, ensuring they reap the benefits they deserve. As experts in our field, we’re well-versed in what works and what doesn’t when it comes to aligning businesses’ perceptions of R&D with the government’s eligibility criteria.

So, if you’re looking for accessible expertise and a proven success rate, you’ll find it with us at Bulletpoint. We’re ready to guide you through the R&D tax incentive process with a blend of professionalism and personality, ensuring your experience with us is not just successful, but enjoyable as well.